These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1721453)

  • 1. Differential effects of FK 506 and cyclosporine on hair regrowth in the DEBR model of alopecia areata.
    Sainsbury TS; Duncan JI; Whiting PH; Hewick DS; Johnson BE; Thomson AW; Oliver RF
    Transplant Proc; 1991 Dec; 23(6):3332-4. PubMed ID: 1721453
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles.
    Verma DD; Verma S; McElwee KJ; Freyschmidt-Paul P; Hoffman R; Fahr A
    Eur J Dermatol; 2004; 14(5):332-8. PubMed ID: 15358573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model.
    McElwee KJ; Rushton DH; Trachy R; Oliver RF
    Br J Dermatol; 1997 Oct; 137(4):491-7. PubMed ID: 9390322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral cyclosporin A restores hair growth in the DEBR rat model for alopecia areata.
    Oliver RF; Lowe JG
    Clin Exp Dermatol; 1995 Mar; 20(2):127-31. PubMed ID: 8565246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
    Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
    Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DEBR rat: an animal model of human alopecia areata.
    Michie HJ; Jahoda CA; Oliver RF; Johnson BE
    Br J Dermatol; 1991 Aug; 125(2):94-100. PubMed ID: 1911310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of mast cells in the alopecia lesion of mice.
    Tanii T; Okada T; Fukai K; Nakagawa K; Hamada T
    Acta Derm Venereol; 1985; 65(1):64-6. PubMed ID: 2578708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata.
    Ito T; Aoshima M; Ito N; Uchiyama I; Sakamoto K; Kawamura T; Yagi H; Hashizume H; Takigawa M
    Arch Dermatol Res; 2009 Jun; 301(5):373-80. PubMed ID: 19301021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of widespread non-pigmented hair regrowth in diffuse alopecia areata.
    Dinh QQ; Chong AH
    Australas J Dermatol; 2007 Nov; 48(4):221-3. PubMed ID: 17956479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata treated with topical minoxidil.
    Weiss VC; West DP; Fu TS; Robinson LA; Cook B; Cohen RL; Chambers DA
    Arch Dermatol; 1984 Apr; 120(4):457-63. PubMed ID: 6703751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DEBR rat, alopecia areata and autoantibodies to the hair follicle.
    McElwee KJ; Pickett P; Oliver RF
    Br J Dermatol; 1996 Jan; 134(1):55-63. PubMed ID: 8745887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata.
    McElwee KJ; Spiers EM; Oliver RF
    Br J Dermatol; 1996 Aug; 135(2):211-7. PubMed ID: 8881662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata.
    Zhang JG; Oliver RF
    Br J Dermatol; 1994 Apr; 130(4):405-14. PubMed ID: 7910477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxity of FK 506: a preliminary study on comparative aspects of FK 506 and cyclosporine nephrotoxicity.
    Nielsen FT; Leyssac PP; Kemp E; Starklint H; Dieperink H
    Transplant Proc; 1994 Dec; 26(6):3104-5. PubMed ID: 7527946
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.
    Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Wahlstrom HE; Sanchez-Urdazpal L; Richards T; Crotty P; Beaver S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):665-8. PubMed ID: 7679835
    [No Abstract]   [Full Text] [Related]  

  • 17. Regrowth of black hair in two red-haired alopecia areata patients.
    Ramot Y; Sinclair RD; Zlotogorski A
    Australas J Dermatol; 2012 Nov; 53(4):e91-2. PubMed ID: 23157795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targetoid hair regrowth in alopecia areata: the wave theory.
    del Río E
    Arch Dermatol; 1998 Aug; 134(8):1042-3. PubMed ID: 9722746
    [No Abstract]   [Full Text] [Related]  

  • 19. Targetoid pattern of hair regrowth in alopecia areata: a case report.
    El-Dars LD; Kamath S; Logan R
    Clin Exp Dermatol; 2009 Apr; 34(3):413. PubMed ID: 19120393
    [No Abstract]   [Full Text] [Related]  

  • 20. Alopecia areata universalis in a dog.
    Ginel PJ; Blanco B; Pérez-Aranda M; Zafra R; Mozos E
    Vet Dermatol; 2015 Oct; 26(5):379-83, e87. PubMed ID: 26123679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.